Overview
Combined Therapeutics Inc. (CTx) is a pre-clinical-stage biotech in the game-changing segment of cancer research that is immunotherapy. The company is converging nanomedicine and biotechnology to enhance the tumoral cells and the tumoral microenvironment targeting. Combined Therapeutics Inc. (or CTx) is an immuno-oncology spin-out of the highly successful and entrepreneurial Langer-Lab at the Massachusetts Institute of Technology (MIT). The first word of our name “Combined” emanates from the fact that we combine our technology with existing immuno-oncology products for a breakthrough in immunotherapy and better patients healthcare.